TG Therapeutics Ownership | Who Owns TG Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

TG Therapeutics Ownership Summary

TG Therapeutics is owned by 42.02% institutional investors, 9.81% insiders, and 48.17% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.09% of TGTX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.25% of its assets in TG Therapeutics shares.

TGTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	TG Therapeutics	42.02%	9.81%	48.17%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	21.90M	15.09%	$659.15M
Vanguard group	15.60M	10.75%	$469.45M
Blackrock	11.39M	7.79%	$202.60M
State street	6.70M	4.58%	$119.12M
Geode capital management	3.19M	2.20%	$96.15M
Pictet asset management sa	2.79M	1.93%	$84.10M
Soleus capital management	2.68M	1.85%	$80.71M
Opaleye management	2.26M	1.56%	$68.03M
Bank of america corp /de/	2.08M	1.42%	$37.04M
Clearbridge investments	1.84M	1.26%	$55.24M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Opaleye management	2.26M	11.90%	$68.03M
Soleus capital management	2.68M	5.07%	$80.71M
M28 capital management lp	161.60K	4.78%	$4.86M
Castellan group	283.68K	3.70%	$8.54M
Ghost tree capital	500.00K	2.79%	$8.89M
683 capital management	697.00K	1.30%	$20.98M
Ikarian capital	291.24K	1.19%	$8.77M
Penn capital management company	351.41K	1.04%	$10.58M
Spotlight asset group	82.10K	1.02%	$1.46M
Quantum private wealth	102.80K	0.99%	$3.09M

Top Buyers

Holder	Shares	% Assets	Change
Clearbridge investments	1.84M	0.04%	1.84M
Blackrock	11.39M	0.00%	544.84K
Raymond james financial	481.99K	0.01%	481.99K
Braun stacey associates	442.81K	0.50%	442.81K
Norges bank	401.50K	0.00%	401.50K

Top Sellers

Holder	Shares	% Assets	Change
Woodline partners lp	-	-	-2.57M
Marshall wace, llp	-	-	-2.05M
Deep track capital, lp	-	-	-1.73M
State street	6.70M	0.01%	-1.10M
Vestal point capital, lp	-	-	-1.05M

New Positions

Holder	Shares	% Assets	Change	Value
Clearbridge investments	1.84M	0.04%	1.84M	$55.24M
Raymond james financial	481.99K	0.01%	481.99K	$14.51M
Braun stacey associates	442.81K	0.50%	442.81K	$13.33M
Norges bank	401.50K	0.00%	401.50K	$12.09M
Penn capital management company	351.41K	1.04%	351.41K	$10.58M

Sold Out

Holder	Change
Global financial private client	-2.00
Mendota financial group	-4.00
Financial gravity asset management	-5.00
Capital performance advisors llp	-23.00
Ica group wealth management	-25.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	194	-40.49%	60,970,728	-39.60%	42	0.87%	109	-42.02%	53	-28.38%
Sep 30, 2024	325	18.18%	100,828,838	8.07%	69	1.67%	187	30.77%	74	10.45%
Jun 30, 2024	273	4.20%	93,287,913	4.27%	63	1.63%	142	12.70%	67	-10.67%
Mar 31, 2024	262	1.16%	89,470,240	-0.55%	62	1.58%	126	9.57%	75	2.74%
Dec 31, 2023	259	0.39%	89,964,121	0.71%	62	1.58%	115	-16.67%	73	25.86%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	8.25M	5.25%	4.70K
Vanguard Total Stock Mkt Idx Inv	4.40M	2.80%	19.12K
Vanguard US Total Market Shares ETF	4.36M	2.78%	3.80K
iShares Russell 2000 ETF	3.67M	2.34%	-31.84K
Vanguard Small Cap Index	3.58M	2.28%	2.92K
SPDR® S&P Biotech ETF	2.23M	1.42%	-23.87K
Vanguard Institutional Extnd Mkt Idx Tr	2.03M	1.29%	12.08K
Vanguard Small Cap Growth Index Inv	2.01M	1.28%	-11.20K
Pictet Biotech	1.79M	1.16%	1.79M
Fidelity Small Cap Index	1.38M	0.88%	-25.81K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 06, 2025	Power Sean A	CFO	Sell	$285.94K
Jan 03, 2025	Power Sean A	CFO	Sell	$343.44K
Nov 11, 2024	Lonial Sagar	-	Sell	$152.20K
Nov 11, 2024	Charney Laurence N	-	Sell	$754.88K
Nov 05, 2024	Echelard Yann	-	Sell	$489.60K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	2
2024 Q4	-	3
2024 Q2	-	2
2024 Q1	-	4
2023 Q3	1	-

TGTX Ownership FAQ

Who Owns TG Therapeutics?

TG Therapeutics shareholders are primarily institutional investors at 42.02%, followed by 9.81% insiders and 48.17% retail investors. The average institutional ownership in TG Therapeutics's industry, Biotech Stocks , is 68.48%, which TG Therapeutics falls below.

Who owns the most shares of TG Therapeutics?

TG Therapeutics’s largest shareholders are Blackrock funding, inc. /de (21.9M shares, 15.09%), Vanguard group (15.6M shares, 10.75%), and Blackrock (11.39M shares, 7.79%). Together, they hold 33.63% of TG Therapeutics’s total shares outstanding.

Does Blackrock own TG Therapeutics?

Yes, BlackRock owns 7.79% of TG Therapeutics, totaling 11.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 202.6M$. In the last quarter, BlackRock increased its holdings by 544.84K shares, a 5.02% change.

Who is TG Therapeutics’s biggest shareholder by percentage of total assets invested?

Opaleye management is TG Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.90% of its assets in 2.26M TG Therapeutics shares, valued at 68.03M$.

Who is the top mutual fund holder of TG Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of TG Therapeutics shares, with 5.25% of its total shares outstanding invested in 8.25M TG Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools